The Journal of Thoracic and Cardiovascular Surgery, Vol 78, 103-109, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation
JG Stone, PF Hoar, AN Faltas, LL Johnson, RN Edie, FO Bowman Jr and JR Malm
To compare the hemodynamic effect of vasodilator therapy on different
regurgitant lesions, we infused sodium nitroprusside intraooperatively in
12 patients with mitral regurgitation and 15 with aortic regurgitation.
During the critical period preceding establishment of cardiopulmonary
bypass, both groups had developed intense vasoconstriction and cardiac
decompensation. All demonstrated improved cardiac function with vasodilator
therapy; however, the degree of improvement with nitroprusside differed in
the two groups. Stroke volume increased 10 ml. per beat per meter squared
in those patients with aortic regurgitation and only 6 ml. per beat per
meter squared in those with mitral regurgitation (p less than 0.05). The
percent increase in stoke volume induced by nitroprusside was inversely
correlated to the preoperative left ventricular ejection fraction (r =
0.44, p less than 0.02). Patients with aortic regurgitation had lower
preoperative left ventricular ejection fractions than those with mitral
regurgitation (0.53 versus 0.63, p less than 0.02). Therefore, we conclude
that patients with aortic regurgitation derived greater intraoperative
hemodynamic benefit from unloading with nitroprusside, because they came to
surgery with greater impairment of left ventricular contractility. Although
nitroprusside improved cardiac function in both groups, only the patients
with aortic regurgitation achieved normal pulmonary artery pressure (17
torr) and pulmonary vascular resistance (2.1 units) as a result of
unloading. Those with mitral regurgitation continued to have pulmonary
hypertension (28 torr) and increased pulmonary vascular resistance (3.9
units) despite vasodilator therapy. Thus the data suggest that patients
with mitral regurgitation derived less hemodynamic benefit from
intraoperative nitroprusside therapy because they were also limited by
right ventricular dysfunction and a less responsive pulmonary vasculature.